| MeSH term | MeSH ID | Detail |
|---|---|---|
| Cholestasis, Extrahepatic | D001651 | 7 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Ischemic Attack, Transient | D002546 | 42 associated lipids |
| Cestode Infections | D002590 | 3 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Common Bile Duct Diseases | D003137 | 3 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
LTC4
Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.
Cross Reference
Introduction
To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with LTC4?
LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with LTC4
PubChem Associated disorders and diseases
What pathways are associated with LTC4
Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with LTC4?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with LTC4?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with LTC4?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with LTC4?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with LTC4?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with LTC4
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bölke E et al. | Changes of gut barrier function during anesthesia and cardiac surgery. | 2001 | Angiology | pmid:11515987 |
| Abad MJ et al. | Effects of furocoumarins from Cachrys trifida on some macrophage functions. | 2001 | J. Pharm. Pharmacol. | pmid:11518028 |
| Wehner J and Neuber K | Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. | 2001 | Br. J. Dermatol. | pmid:11531797 |
| Tornhamre S et al. | Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. | 2001 | Biochem. Pharmacol. | pmid:11543725 |
| Malaviya R and Uckun FM | Leflunomide metabolite analogue alpha-cyano-beta-hydroxy-beta-methyl-N-[3-(trifluoromethyl)phenyl]propenamide inhibits IgE/FcepsilonRI receptor-mediated mast cell leukotriene release and allergic asthma in mice. | 2001 Sep-Oct | Am J Ther | pmid:11550070 |
| Sano A et al. | Regulation of eosinophil function by phosphatidylinositol-specific PLC and cytosolic PLA(2). | 2001 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:11557588 |
| Thomas LL et al. | Peptide-based analysis of amino acid sequences important to the biological activity of eosinophil granule major basic protein. | 2001 | Immunol. Lett. | pmid:11578692 |
| Kamohara M et al. | Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells. | 2001 | Biochem. Biophys. Res. Commun. | pmid:11587533 |
| Schroeder JT et al. | Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. | 2001 | Clin. Exp. Allergy | pmid:11591186 |
| Hui Y et al. | The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization. | 2001 | J. Biol. Chem. | pmid:11591709 |
| Duffy SM et al. | Resting and activation-dependent ion channels in human mast cells. | 2001 | J. Immunol. | pmid:11591748 |
| Ohno N et al. | Prognostic significance of multidrug resistance protein in adult T-cell leukemia. | 2001 | Clin. Cancer Res. | pmid:11595704 |
| Terlouw SA et al. | Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells. | 2001 | Br. J. Pharmacol. | pmid:11682439 |
| Miura K et al. | Piceatannol is an effective inhibitor of IgE-mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs. | 2001 | Clin. Exp. Allergy | pmid:11696049 |
| Bölke E et al. | Inflammatory response during abdominal and thyroid surgery: a prospective clinical trial on mediator release. | 2001 | Shock | pmid:11699069 |
| Martin V et al. | Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors. | 2001 | Biochem. Pharmacol. | pmid:11705452 |
| Fernández MA et al. | New insights into the mechanism of action of the anti-inflammatory triterpene lupeol. | 2001 | J. Pharm. Pharmacol. | pmid:11732756 |
| Miura K et al. | Localizing a control region in the pathway to leukotriene C(4) secretion following stimulation of human basophils with anti-IgE antibody. | 2001 | J. Immunol. | pmid:11739523 |
| Miller DS et al. | Xenobiotic efflux pumps in isolated fish brain capillaries. | 2002 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:11742838 |
| Malaviya R and Uckun FM | Role of STAT6 in IgE receptor/FcepsilonRI-mediated late phase allergic responses of mast cells. | 2002 | J. Immunol. | pmid:11751988 |